Top 45 Vivo Capital, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ERAS | Erasca Inc | 16.41% | 12.15M | $196.6M | +31.04%(+2.88M) | $3.94(+368.45%) | 2026-03-31 | |
| PRAX | Praxis Precision Medicines | 9.11% | 338.9K | $109.2M | +3.04%(+10.00K) | $100.14(+218.06%) | 2026-03-31 | |
| TERN | Terns Pharmaceuticals Inc | 5.87% | 1.33M | $70.4M | -75.04%(-4.01M) | $11.35(+366.65%) | 2026-03-31 | |
| TRVI | Trevi Therapeutics Inc | 5.07% | 5.09M | $60.8M | +0.00%(+0) | $4.42(+305.79%) | 2026-03-31 | |
| DBVT | DBV Technologies SA | 4.65% | 2.67M | $55.7M | +8.37%(+205.94K) | $12.24(+29.30%) | 2026-03-31 | |
| CMPX | Compass Therapeutics Inc | 4.21% | 9.55M | $50.5M | +0.00%(+0) | $3.00(-24.39%) | 2026-03-31 | |
| TNGX | Tango Therapeutics Inc | 3.76% | 2.15M | $45.1M | +0.00%(+0) | $6.99(+321.39%) | 2026-03-31 | |
| SABS | SAB Biotherapeutics Inc | 3.65% | 11.42M | $43.7M | +0.00%(+0) | $1.88(+108.23%) | 2026-03-31 | |
| CRVS | Corvus Pharmaceuticals Holdings | 3.43% | 2.81M | $41.0M | +25.56%(+571.25K) | $5.56(+173.72%) | 2026-03-31 | |
| DRUG | Bright Minds Biosciences Inc | 3.39% | 557.2K | $40.7M | +11.08%(+55.55K) | $35.39(+90.99%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +24.22% | +91.68% |
| Top 20 Holdings Unweighted | +43.72% | +196.85% |
Sign up free to track Vivo Capital, LLC, compare funds side by side, and get alerts the moment positions change.